The Global Opioids Market
The Global Opioids Market was valued at US$ 42,429 Mn in 2021 and would rocket up to US$ 50,432 Mn by 2027 at a CAGR 2.8% from 2022-2027.
Opioids are the medication utilized for the treatment of severe or continuous pain such as chronic headaches, backaches, by patients either recovering from surgery or undergoing severe pain associated with cancer, and by adults and children who got injured playing sports or those who have been severely injured in fall, auto accident or other incidents. Opioids are also called as narcotics. Physicians prescribe various types of Opioids in different strengths that can be consumed in various forms, according to the patient, the situation, and the Type and level of pain. Even though some Opioids are used to treat cough & diarrhea.
Market Drivers
Many people suffering with chronic pains globally which is anticipated to drive the growth of global opioid market. The key elements which drive the growth of market involve the rise in admistration of these drugs to reduce pain & increase in the geriatric population which ids majorly susceptible to orthopedic pain. Growing consumption of opioids analgesic for pain management in developing regions is expected to make profitable opportunities for market growth during the forecast period.
Market Restraints
Origination and validation of cannabis as an alternative to opioids hamper the growth of the market. Side effects associated with opioids are expected to impede to market growth over the forecast period. Side effect of opioids such as patient may suffer from constipation, nausea & vomiting when patient starts consuming opioids which restraints the growth of Opioids market. Also, market players are concentrating on launching non-opioid pain treatment products which is responsible for restraints the market growth.
Market Segmentation
The Global Opioids Market is segmented into Product Type, Route of Administration, Distribution Channel, Application. By Product Type such as Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Others. By Rout of Administration such as Oral, Topical, Parenteral, Others. By Distribution Channel such as Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. By Application such as Pain Management, Cough Treatment, Diarrhea Treatment.
Regional Analysis
The Global Opioids Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to hold superior position in the Global Opioids Market during the forecast period due to rising number of product approvals by regulatory authorities. US has largest market for Opioids due to strong healthcare infrastructure, high medical care accessibility, and strong presence of local players. Canada is anticipated to witness significant growth in the market because of high spending in public health infrastructure, government initiatives, decrease in medication costs, and growing healthcare expenditure per capita.
Key Players
Various Key Players are listed in this report such as Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc.,
Market Taxonomy
By Product Type
By Route of Administration
By Distribution Channel
By Application
By Region
Global Opioids Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Opioids Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Opioids Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Opioids Market Share Analysis, By Product Type
5.3 Global Opioids Market Size and Forecast, By Product Type
5.3.1 Methadone
5.3.2 Codeine
5.3.3 Fentanyl
5.3.4 Oxycodone
5.3.5 Morphine
5.3.6 Hydrocodone
5.3.7 Others.
6 Global Opioids Market, By Route of Administration
6.1 Y-o-Y Growth Comparison, By Route of Administration
6.2 Global Opioids Market Share Analysis, By Route of Administration
6.3 Global Opioids Market Size and Forecast, By Route of Administration
6.3.1 Oral
6.3.2 Topical
6.3.3 Parenteral
6.3.4 Others
7 Global Opioids Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Opioids Market Share Analysis, By Distribution Channel
7.3 Global Opioids Market Size and Forecast, By Distribution Channel
7.3.1 Hospital Pharmacies
7.3.2 Retail Pharmacies
7.3.3 Online Pharmacies
8 Global Opioids Market, By Application
8.1 Y-o-Y Growth Comparison, By Application
8.2 Global Opioids Market Share Analysis, Application
8.3 Global Opioids Market Size and Forecast, By Application
8.3.1 Pain Management
8.3.2 Cough Treatment
8.3.3 Diarrhea Treatment.
9 Global Opioids Market, By Region
9.1 Global Opioids Market Share Analysis, By Region
9.2 Global Opioids Market Share Analysis, By Region
9.3 Global Opioids Market Size and Forecast, By Region
10 North America Opioids Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 North America Opioids Market Share Analysis, By Product Type
10.3 North America Opioids Market Share Analysis, By Route of Administration
10.4 North America Opioids Market Size and Forecast, By Distribution Channel
10.5 North America Opioids Market Size and Forecast, By Application
10.6 North America Opioids Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico
11 Europe Opioids Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Europe Opioids Market Share Analysis, By Product Type
11.3 Europe Opioids Market Share Analysis, By Route of Administration
11.4 Europe Opioids Market Size and Forecast, By Distribution Channel
11.5 Europe Opioids Market Size and Forecast, By Application
11.6 Europe Opioids Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4. Rest of Europe
12 Asia Pacific Opioids Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Asia Pacific Opioids Market Share Analysis, By Product Type
12.3 Asia Pacific Opioids Market Share Analysis, By Route of Administration
12.4 Asia Pacific Opioids Market Size and Forecast, By Distribution Channel
12.5 Asia Pacific Opioids Market Size and Forecast, By Application
12.6 Asia Pacific Opioids Market Size and Forecast, By Country
12.6.1 China
12.7.2 Japan
12.8.3 India
12.8.4. Rest of Asia Pacific
13 Latin America Opioids Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Latin America Opioids Market Share Analysis, By Product Type
13.3 Latin America Opioids Market Share Analysis, By Route of Administration
13.4 Latin America Opioids Market Size and Forecast, By Distribution Channel
13.5 Latin America Opioids Market Size and Forecast, By Application
13.6 Latin America Opioids Market Size and Forecast, Country
13.6.1. Brazil
13.6.2. Rest of Latin America
14 Middle East Opioids Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Middle East Opioids Market Share Analysis, By Product Type
14.3 Middle East Opioids Market Share Analysis, By Route of Administration
14.4 Middle East Opioids Market Size and Forecast, By Distribution Channel
14.5 Middle East Opioids Market Size and Forecast, By Application
14.6 Middle East Opioids Market Size and Forecast, By Country
14.6.1. Saudi Arabia
14.6.2. UAE
14.6.3. Egypt
14.6.4. Kuwait
14.6.5. South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 Teva Pharmaceutical Industries Ltd
16.1.1 Overview
16.1.2 Products
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Johnson & Johnson
16.2.1 Overview
16.2.2 Products
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Endo International plc
16.3.1 Overview
16.3.2 Products
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Lupin Limited
16.4.1 Overview
16.4.2 Products
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Cadila Healthcare Limited
16.5.1 Overview
16.5.2 Products
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Purdue Pharma L.P
16.6.1 Overview
16.6.2 Products
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 AbbVie Inc.
16.7.1 Overview
16.7.2 Products
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 Fresenius Kabi
16.8.1 Overview
16.8.2 Products
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Mallinckrodt Pharmaceuticals
16.9.1 Overview
16.9.2 Products
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 Pfizer Inc.
16.10.1 Overview
16.10.2 Products
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies
